Anti-neutrophil cytoplasmic antibodies (ANCAs) specific for leukocyte proteinase 3 and myeloperoxidase — PR3-ANCAs and MPO-ANCAs, respectively — define distinct conditions among patients with ...
Intravenous drip Use of the drug resulted in remission of severe pulmonary and cutaneous ANCA-associated vasculitis that resisted intensive conventional treatment. Daratumumab, a monoclonal antibody, ...
Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) who presented with antimyeloperoxidase (anti-MPO) ANCA appeared to have a higher risk for major adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results